Paul R. Sleath
- Epidemiology top 2%
- Immunology top 2%
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Co-authors
- Roy A. BlackС. KronheimKenneth H. GrabsteinDavid J. PickupGuy S. SalvesenCaroline A. RayNancy HoskenFlorian Kern
- Topics
- Pharmacogenetics and Drug Metabolism (4 papers)Research on Leishmaniasis Studies (4 papers)Herpesvirus Infections and Treatments (4 papers)
- Cited by
- ImmunologyVirologyEpidemiology
- Partner nations
- United StatesBrazilCanada
In The Last Decade
Paul R. Sleath
22 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Epidemiology 1.4k
- Immunology 1.4k
- Molecular Biology 1.2k
- Oncology 571
- Cancer Research 327
Countries citing papers authored by Paul R. Sleath
This map shows the geographic impact of Paul R. Sleath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Sleath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Sleath more than expected).
Fields of papers citing papers by Paul R. Sleath
This network shows the impact of papers produced by Paul R. Sleath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Sleath. The network helps show where Paul R. Sleath may publish in the future.
Co-authorship network of co-authors of Paul R. Sleath
This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. Sleath. A scholar is included among the top collaborators of Paul R. Sleath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. Sleath. Paul R. Sleath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer. | 9 |
| 2 | 91 | |
| 3 | Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjectsbreakdown → | 1040 |
| 4 | 2 | |
| 5 | Serum antibodies to lipophilin B detected in late stage breast cancer patients. | 17 |
| 6 | 24 | |
| 7 | 36 | |
| 8 | 36 | |
| 9 | 66 | |
| 10 | Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine. | 272 |
| 11 | 1 | |
| 12 | 101 | |
| 13 | Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingbreakdown → | 524 |
| 14 | 3 | |
| 15 | Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzymebreakdown → | 836 |
| 16 | 211 | |
| 17 | 70 | |
| 18 | 12 | |
| 19 | 25 | |
| 20 | 6 |
About Paul R. Sleath
Paul R. Sleath is a scholar working on Pharmacology, Immunology and Virology, having authored 22 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Research on Leishmaniasis Studies (4 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Immunology (1.4k citations), Virology (293 citations) and Epidemiology (1.4k citations). Paul R. Sleath has collaborated with scholars based in United States, Brazil and Canada. Frequent co-authors include Roy A. Black, С. Kronheim, Kenneth H. Grabstein, David J. Pickup, Guy S. Salvesen, Caroline A. Ray, Nancy Hosken, Florian Kern, Louis J. Picker and Jay A. Nelson. Their work appears in journals such as Nature, Cell and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.